. .
Bruker Daltonics
Bruker

Advances in Molecular Histology with the MALDI Molecular Imager

Type: Application

Application Note

Expression Proteomics, Clinical Proteomics

Number: Technology

MT-89

MALDI-TOF

Year Products

2007

  Author
 

Sören-Oliver Deininger1, René Krieg1, Sandra Rauser2, Axel Walch2 [1] Bruker Daltonik GmbH, Bremen, Germany [2] Institute of Pathology, GSF Neuherberg, Germany

  Reference
 

Application Note # MT-89

 

Abstract

 

As MALDI molecular imaging technology attracts increasing attention in the field of histopathology, obviously one feature is most crucial to the interpretation of the MALDI images: Their unambiguous correlation with histology. First attempts involved either histological staining of the tissue sample with a MALDI compatible dye followed by MALDI imaging analysis or histological staining and MALDI imaging of consecutive sections. Both approaches have limitations: The conclusions obtained from MALDI compatible stains are limited and the histological details observed on consecutive sections are impossible to match at the 20 - 50 μm level. However, a new approach provides a significant step towards molecular histologyTM: „Post acquisition staining“, i. e. the staining of the sample after the MALDI spectra acquisition on the same tissue section [1,2]. This approach allows the full scale interpretation of the MALDI imaging result both on the molecular and on the histological level with unambiguous correlation on the 20 - 50 μm level.

 

Related Products

 

ImagePrep
flexImaging
Tissue Imaging

 

Download

 

Register with us
In order to get access to all our multimedia specials, additional content and to subscribe to our informative Daltonics E-Dispatch newsletter, please register to our website.